Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bosque

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Nanomedicine (London, England)|February 3, 2023
PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agentPreethi B Balakrishnan, Carissa S Holmberg, Debbie K Ledezma, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitroChristina Gavegnano, Mervi Detorio, Catherine Montero, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic PatientsAdam M Spivak, Alberto Bosque, Alfred H Balch, et al.
Journal of Virology|February 21, 2012
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activityFrank Wolschendorf, Alberto Bosque, Takao Shishido, et al.
Retrovirology|July 29, 2015
HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteinsPeter W Ramirez, Ana Beatriz DePaula-Silva, Matt Szaniawski, et al.
Scientific Reports|December 9, 2021
An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixesCallie Levinger, J Natalie Howard, Jie Cheng, et al.
Molecular Therapy. Oncology|June 16, 2025
Targeted expansion of cytotoxic T cells using IL-12 and CD137L supplementation enhances antitumor efficacyMarta Sanz, Brendan T Mann, Elyse K McMahon, et al.
International Journal of Molecular Sciences|October 22, 2020
Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIVTinus Schynkel, Matthew A Szaniawski, Adam M Spivak, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Apo2L/TRAIL and immune regulationAlberto Anel, Alberto Bosque, Javier Naval, et al.
Proteomics|August 21, 2009
Quantitative DY-maleimide-based proteomic 2-DE-labeling strategies using human skin proteinsLisa Dietz, Alberto Bosque, Patrick Pankert, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Nanomedicine (London, England)|February 3, 2023
PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agentPreethi B Balakrishnan, Carissa S Holmberg, Debbie K Ledezma, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitroChristina Gavegnano, Mervi Detorio, Catherine Montero, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic PatientsAdam M Spivak, Alberto Bosque, Alfred H Balch, et al.
Journal of Virology|February 21, 2012
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activityFrank Wolschendorf, Alberto Bosque, Takao Shishido, et al.
Retrovirology|July 29, 2015
HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteinsPeter W Ramirez, Ana Beatriz DePaula-Silva, Matt Szaniawski, et al.
Scientific Reports|December 9, 2021
An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixesCallie Levinger, J Natalie Howard, Jie Cheng, et al.
Molecular Therapy. Oncology|June 16, 2025
Targeted expansion of cytotoxic T cells using IL-12 and CD137L supplementation enhances antitumor efficacyMarta Sanz, Brendan T Mann, Elyse K McMahon, et al.
International Journal of Molecular Sciences|October 22, 2020
Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIVTinus Schynkel, Matthew A Szaniawski, Adam M Spivak, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Apo2L/TRAIL and immune regulationAlberto Anel, Alberto Bosque, Javier Naval, et al.
Proteomics|August 21, 2009
Quantitative DY-maleimide-based proteomic 2-DE-labeling strategies using human skin proteinsLisa Dietz, Alberto Bosque, Patrick Pankert, et al.
Pageof 9